(Bloomberg) Baring Private Equity Asia is in advanced talks to acquire content outsourcing company Straive from Swiss buyout firm Partners Group Holding AG, according to people familiar with the matter. The parties are finalizing the details of a transaction to buy Straive, formerly known as SPi Global, for about $1 billion, the people said. Baring has emerged as the preferred buyer of the business after outbidding other private equity firms, the people said. An announcement could come as early as this month, the people said. Talks could still be delayed or fall apart, they said. Representatives for Baring and Partners Group declined to comment. A deal would mark Baring’s second sizable acquisition this month after it agreed to buy Hinduja Global Solutions Ltd.’s health-care services business at an enterprise value of $1.2 billion. Partners Group has been exploring a sale of Straive as other potential investors had shown interest in acquiring the company, Bloomberg News first rep
Baring Said in Advanced Talks for $1 Billion Straive Acquisition swissinfo.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swissinfo.ch Daily Mail and Mail on Sunday newspapers.
Atlantia's (ATL.MI) toll road payment unit Telepass sees an initial public offering (IPO) as an option from 2024 to allow minority shareholder Partners Group Holding (PGHN.S) to cash in, Il Sole 24 Ore quoted Telepass' chief executive as saying.
Bridgepoint Valued at $3 9 Billion in Rare London Buyout IPO bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Jul 19 2021, 7:29 AM
July 18 2021, 5:10 PM
July 19 2021, 7:29 AM
(Bloomberg)
(Bloomberg)
Partners Group Holding AG is nearing a deal to acquire European generic drugmaker Pharmathen SA from BC Partners for around 1.6 billion euros ($1.9 billion), according to people familiar with the matter.
The buyout firms could announce an agreement in the coming days, the people said, asking not to be identified discussing confidential information. Partners Group preempted other private equity and strategic bidders to win the planned auction of the drugmaker, they said.
Founded in 1969 in Athens, Pharmathen develops and manufactures generic drugs that can be administered via tablets, drops and injection. Last year, the company had more than 30 products being lined up for launch, with a focus on the lucrative U.S. market, according to a company video. BC Partners acquired Pharmathen from its founding family for 475 million euros in 2015.